SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-027618
Filing Date
2024-02-08
Accepted
2024-02-08 08:20:53
Documents
15
Period of Report
2024-02-06
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d774086d8ka.htm   iXBRL 8-K/A 27006
2 EX-4.2 d774086dex42.htm EX-4.2 92635
  Complete submission text file 0001193125-24-027618.txt   273674

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vcnx-20240206.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vcnx-20240206_lab.xml EX-101.LAB 18684
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vcnx-20240206_pre.xml EX-101.PRE 11685
17 EXTRACTED XBRL INSTANCE DOCUMENT d774086d8ka_htm.xml XML 4503
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38624 | Film No.: 24606953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)